nodes	percent_of_prediction	percent_of_DWPC	metapath
Desipramine—ABCB1—Topotecan—cervical cancer	0.154	0.625	CbGbCtD
Desipramine—CYP3A4—Topotecan—cervical cancer	0.0923	0.375	CbGbCtD
Desipramine—CHRM3—ureter—cervical cancer	0.0783	0.14	CbGeAlD
Desipramine—SMPD1—decidua—cervical cancer	0.017	0.0304	CbGeAlD
Desipramine—SMPD1—renal system—cervical cancer	0.0167	0.0298	CbGeAlD
Desipramine—CHRM3—exocrine gland—cervical cancer	0.0154	0.0275	CbGeAlD
Desipramine—CYP2C18—uterine cervix—cervical cancer	0.0145	0.0259	CbGeAlD
Desipramine—SMPD1—female reproductive system—cervical cancer	0.0134	0.0239	CbGeAlD
Desipramine—CYP2C18—mammalian vulva—cervical cancer	0.0127	0.0227	CbGeAlD
Desipramine—SMPD1—female gonad—cervical cancer	0.0122	0.0217	CbGeAlD
Desipramine—SMPD1—vagina—cervical cancer	0.0121	0.0216	CbGeAlD
Desipramine—CHRM5—epithelium—cervical cancer	0.012	0.0214	CbGeAlD
Desipramine—SLC22A2—renal system—cervical cancer	0.0106	0.019	CbGeAlD
Desipramine—CYP2C18—vagina—cervical cancer	0.00986	0.0176	CbGeAlD
Desipramine—SLC22A4—decidua—cervical cancer	0.00802	0.0143	CbGeAlD
Desipramine—ORM1—endometrium—cervical cancer	0.00792	0.0141	CbGeAlD
Desipramine—SLC22A4—renal system—cervical cancer	0.00788	0.0141	CbGeAlD
Desipramine—SMPD1—lymph node—cervical cancer	0.00784	0.014	CbGeAlD
Desipramine—SLC22A3—uterine cervix—cervical cancer	0.00767	0.0137	CbGeAlD
Desipramine—SLC22A4—endometrium—cervical cancer	0.00762	0.0136	CbGeAlD
Desipramine—SLC22A1—renal system—cervical cancer	0.0075	0.0134	CbGeAlD
Desipramine—SLC22A3—renal system—cervical cancer	0.00717	0.0128	CbGeAlD
Desipramine—SLC22A3—endometrium—cervical cancer	0.00693	0.0124	CbGeAlD
Desipramine—SLC22A3—mammalian vulva—cervical cancer	0.00671	0.012	CbGeAlD
Desipramine—ORM1—female reproductive system—cervical cancer	0.00656	0.0117	CbGeAlD
Desipramine—CYP2A6—vagina—cervical cancer	0.00651	0.0116	CbGeAlD
Desipramine—SLC22A4—female reproductive system—cervical cancer	0.00631	0.0113	CbGeAlD
Desipramine—SLC6A2—decidua—cervical cancer	0.00626	0.0112	CbGeAlD
Desipramine—CHRM3—renal system—cervical cancer	0.00622	0.0111	CbGeAlD
Desipramine—HTR1A—renal system—cervical cancer	0.0062	0.0111	CbGeAlD
Desipramine—HTR2C—female reproductive system—cervical cancer	0.0059	0.0105	CbGeAlD
Desipramine—ADRB1—female reproductive system—cervical cancer	0.00579	0.0103	CbGeAlD
Desipramine—Benazepril—MTHFR—cervical cancer	0.00577	1	CrCbGaD
Desipramine—SLC22A3—female reproductive system—cervical cancer	0.00574	0.0102	CbGeAlD
Desipramine—SLC22A4—vagina—cervical cancer	0.00571	0.0102	CbGeAlD
Desipramine—SLC6A4—female reproductive system—cervical cancer	0.00559	0.00997	CbGeAlD
Desipramine—SLC22A5—uterine cervix—cervical cancer	0.00557	0.00994	CbGeAlD
Desipramine—CHRM1—female reproductive system—cervical cancer	0.00557	0.00994	CbGeAlD
Desipramine—SLC22A1—vagina—cervical cancer	0.00543	0.0097	CbGeAlD
Desipramine—SLC22A3—female gonad—cervical cancer	0.00523	0.00932	CbGeAlD
Desipramine—SLC22A5—renal system—cervical cancer	0.00521	0.0093	CbGeAlD
Desipramine—SLC22A3—vagina—cervical cancer	0.00519	0.00927	CbGeAlD
Desipramine—SLC22A5—endometrium—cervical cancer	0.00504	0.00899	CbGeAlD
Desipramine—CHRM3—female reproductive system—cervical cancer	0.00498	0.00889	CbGeAlD
Desipramine—SLC6A2—female reproductive system—cervical cancer	0.00492	0.00878	CbGeAlD
Desipramine—HRH1—epithelium—cervical cancer	0.00477	0.00851	CbGeAlD
Desipramine—HRH1—uterine cervix—cervical cancer	0.00473	0.00843	CbGeAlD
Desipramine—CYP1A2—renal system—cervical cancer	0.00472	0.00843	CbGeAlD
Desipramine—CHRM3—female gonad—cervical cancer	0.00453	0.00809	CbGeAlD
Desipramine—CYP2B6—renal system—cervical cancer	0.00453	0.00808	CbGeAlD
Desipramine—HRH1—decidua—cervical cancer	0.0045	0.00804	CbGeAlD
Desipramine—HRH1—endometrium—cervical cancer	0.00428	0.00763	CbGeAlD
Desipramine—CYP2E1—renal system—cervical cancer	0.00425	0.00758	CbGeAlD
Desipramine—CYP2C19—vagina—cervical cancer	0.00419	0.00747	CbGeAlD
Desipramine—SLC22A5—female reproductive system—cervical cancer	0.00418	0.00745	CbGeAlD
Desipramine—HRH1—mammalian vulva—cervical cancer	0.00414	0.00738	CbGeAlD
Desipramine—HTR2A—epithelium—cervical cancer	0.00398	0.0071	CbGeAlD
Desipramine—ORM1—lymph node—cervical cancer	0.00384	0.00685	CbGeAlD
Desipramine—SLC22A5—female gonad—cervical cancer	0.0038	0.00678	CbGeAlD
Desipramine—SLC22A5—vagina—cervical cancer	0.00378	0.00674	CbGeAlD
Desipramine—HTR2A—renal system—cervical cancer	0.00369	0.00659	CbGeAlD
Desipramine—SLC22A4—lymph node—cervical cancer	0.00369	0.00659	CbGeAlD
Desipramine—CYP2B6—female reproductive system—cervical cancer	0.00363	0.00647	CbGeAlD
Desipramine—HRH1—female reproductive system—cervical cancer	0.00354	0.00632	CbGeAlD
Desipramine—CYP3A4—renal system—cervical cancer	0.00342	0.0061	CbGeAlD
Desipramine—CYP2E1—female reproductive system—cervical cancer	0.0034	0.00607	CbGeAlD
Desipramine—CYP2D6—renal system—cervical cancer	0.00336	0.006	CbGeAlD
Desipramine—SLC22A3—lymph node—cervical cancer	0.00336	0.00599	CbGeAlD
Desipramine—CYP2B6—vagina—cervical cancer	0.00328	0.00585	CbGeAlD
Desipramine—HRH1—female gonad—cervical cancer	0.00322	0.00575	CbGeAlD
Desipramine—HRH1—vagina—cervical cancer	0.0032	0.00571	CbGeAlD
Desipramine—HTR2A—female reproductive system—cervical cancer	0.00296	0.00528	CbGeAlD
Desipramine—SLC6A2—lymph node—cervical cancer	0.00288	0.00514	CbGeAlD
Desipramine—CYP3A4—female reproductive system—cervical cancer	0.00274	0.00489	CbGeAlD
Desipramine—CYP2D6—female reproductive system—cervical cancer	0.00269	0.00481	CbGeAlD
Desipramine—HTR2A—vagina—cervical cancer	0.00268	0.00477	CbGeAlD
Desipramine—ABCB1—epithelium—cervical cancer	0.00261	0.00466	CbGeAlD
Desipramine—ABCB1—uterine cervix—cervical cancer	0.00259	0.00462	CbGeAlD
Desipramine—ABCB1—decidua—cervical cancer	0.00246	0.0044	CbGeAlD
Desipramine—CYP2D6—female gonad—cervical cancer	0.00245	0.00437	CbGeAlD
Desipramine—SLC22A5—lymph node—cervical cancer	0.00244	0.00436	CbGeAlD
Desipramine—ABCB1—renal system—cervical cancer	0.00242	0.00432	CbGeAlD
Desipramine—ABCB1—endometrium—cervical cancer	0.00234	0.00417	CbGeAlD
Desipramine—ABCB1—mammalian vulva—cervical cancer	0.00226	0.00404	CbGeAlD
Desipramine—ABCB1—uterus—cervical cancer	0.00216	0.00385	CbGeAlD
Desipramine—HRH1—lymph node—cervical cancer	0.00207	0.0037	CbGeAlD
Desipramine—ABCB1—female reproductive system—cervical cancer	0.00194	0.00346	CbGeAlD
Desipramine—ABCB1—female gonad—cervical cancer	0.00176	0.00315	CbGeAlD
Desipramine—ABCB1—vagina—cervical cancer	0.00175	0.00313	CbGeAlD
Desipramine—ABCB1—lymph node—cervical cancer	0.00113	0.00202	CbGeAlD
Desipramine—CHRM2—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.000203	0.00109	CbGpPWpGaD
Desipramine—CHRM3—GPCR downstream signaling—AKAP13—cervical cancer	0.000203	0.00108	CbGpPWpGaD
Desipramine—CHRM2—GPCR downstream signaling—AKAP13—cervical cancer	0.000201	0.00107	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—WNT5A—cervical cancer	0.000194	0.00104	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TAAR6—cervical cancer	0.000194	0.00104	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—WNT5A—cervical cancer	0.00019	0.00102	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TAAR6—cervical cancer	0.00019	0.00101	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—AKAP13—cervical cancer	0.000189	0.00101	CbGpPWpGaD
Desipramine—SLC6A4—Circadian rythm related genes—TP53—cervical cancer	0.000187	0.000997	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—AKAP13—cervical cancer	0.000186	0.000993	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—WNT5A—cervical cancer	0.000186	0.000993	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—AKAP13—cervical cancer	0.000186	0.000991	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TAAR6—cervical cancer	0.000186	0.000991	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—AKAP13—cervical cancer	0.000185	0.000988	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—WNT5A—cervical cancer	0.000185	0.000988	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TAAR6—cervical cancer	0.000185	0.000986	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—WNT2—cervical cancer	0.000185	0.000986	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—AKAP13—cervical cancer	0.000184	0.000985	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—AKAP13—cervical cancer	0.000183	0.000975	CbGpPWpGaD
Desipramine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000179	0.000957	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—WNT2—cervical cancer	0.000177	0.000944	CbGpPWpGaD
Desipramine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—cervical cancer	0.000169	0.000904	CbGpPWpGaD
Desipramine—CHRM3—Regulation of Actin Cytoskeleton—EGFR—cervical cancer	0.000169	0.000901	CbGpPWpGaD
Desipramine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—cervical cancer	0.000167	0.000892	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—WNT5A—cervical cancer	0.000163	0.000872	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TAAR6—cervical cancer	0.000163	0.00087	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—CA9—cervical cancer	0.000163	0.000869	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—AKAP13—cervical cancer	0.000162	0.000866	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—WNT5A—cervical cancer	0.000161	0.000858	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TAAR6—cervical cancer	0.00016	0.000856	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—WNT5A—cervical cancer	0.00016	0.000856	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TAAR6—cervical cancer	0.00016	0.000854	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—WNT5A—cervical cancer	0.00016	0.000853	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TAAR6—cervical cancer	0.00016	0.000852	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—WNT5A—cervical cancer	0.000159	0.00085	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TAAR6—cervical cancer	0.000159	0.000849	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—WNT5A—cervical cancer	0.000158	0.000842	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TAAR6—cervical cancer	0.000157	0.000841	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—AKAP13—cervical cancer	0.000155	0.000829	CbGpPWpGaD
Desipramine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000152	0.000811	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—CA9—cervical cancer	0.000152	0.00081	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—WNT2—cervical cancer	0.000152	0.000809	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—CA9—cervical cancer	0.000149	0.000798	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—WNT2—cervical cancer	0.000148	0.000791	CbGpPWpGaD
Desipramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000146	0.00078	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—WNT2—cervical cancer	0.000145	0.000774	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—WNT2—cervical cancer	0.000144	0.00077	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—CA9—cervical cancer	0.00014	0.000748	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—WNT5A—cervical cancer	0.00014	0.000747	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—WNT5A—cervical cancer	0.000134	0.000716	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—AKAP13—cervical cancer	0.000133	0.00071	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—AKAP13—cervical cancer	0.00013	0.000695	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—WNT2—cervical cancer	0.000127	0.000679	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—AKAP13—cervical cancer	0.000127	0.000679	CbGpPWpGaD
Desipramine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000127	0.000678	CbGpPWpGaD
Desipramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000127	0.000676	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—AKAP13—cervical cancer	0.000127	0.000676	CbGpPWpGaD
Desipramine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000126	0.000674	CbGpPWpGaD
Desipramine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000126	0.000672	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—WNT2—cervical cancer	0.000125	0.000668	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—WNT2—cervical cancer	0.000125	0.000667	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—WNT2—cervical cancer	0.000125	0.000665	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—WNT2—cervical cancer	0.000124	0.000663	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—WNT2—cervical cancer	0.000123	0.000656	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—CA9—cervical cancer	0.000121	0.000644	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—CA9—cervical cancer	0.000118	0.000631	CbGpPWpGaD
Desipramine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000115	0.000614	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—WNT5A—cervical cancer	0.000115	0.000613	CbGpPWpGaD
Desipramine—DRD2—Circadian rythm related genes—TP53—cervical cancer	0.000114	0.00061	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—WNT5A—cervical cancer	0.000112	0.0006	CbGpPWpGaD
Desipramine—CHRM1—Circadian rythm related genes—TP53—cervical cancer	0.000112	0.000597	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—AKAP13—cervical cancer	0.000112	0.000596	CbGpPWpGaD
Desipramine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.000111	0.000592	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—AKAP13—cervical cancer	0.00011	0.000587	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—WNT5A—cervical cancer	0.00011	0.000586	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—AKAP13—cervical cancer	0.00011	0.000586	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—AKAP13—cervical cancer	0.000109	0.000584	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—WNT5A—cervical cancer	0.000109	0.000583	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—AKAP13—cervical cancer	0.000109	0.000582	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—AKAP13—cervical cancer	0.000108	0.000576	CbGpPWpGaD
Desipramine—SLC22A3—Metabolism—MTHFR—cervical cancer	0.000105	0.000562	CbGpPWpGaD
Desipramine—CYP2C18—Metabolism—MTHFR—cervical cancer	9.95e-05	0.000531	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—NOTCH2—cervical cancer	9.82e-05	0.000524	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—WNT5A—cervical cancer	9.64e-05	0.000515	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—WNT5A—cervical cancer	9.49e-05	0.000507	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—WNT5A—cervical cancer	9.47e-05	0.000505	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—WNT5A—cervical cancer	9.44e-05	0.000504	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—NOTCH2—cervical cancer	9.41e-05	0.000502	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—WNT5A—cervical cancer	9.41e-05	0.000502	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—WNT5A—cervical cancer	9.32e-05	0.000497	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—CA9—cervical cancer	9.11e-05	0.000487	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—CA9—cervical cancer	8.9e-05	0.000475	CbGpPWpGaD
Desipramine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	8.78e-05	0.000469	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—CA9—cervical cancer	8.38e-05	0.000448	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—NOTCH2—cervical cancer	8.06e-05	0.00043	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—HES1—cervical cancer	8.05e-05	0.00043	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—NOTCH2—cervical cancer	7.88e-05	0.000421	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—HES1—cervical cancer	7.71e-05	0.000412	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—NOTCH2—cervical cancer	7.71e-05	0.000412	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—NOTCH2—cervical cancer	7.67e-05	0.000409	CbGpPWpGaD
Desipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	7.37e-05	0.000393	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—CA9—cervical cancer	7.1e-05	0.000379	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—TERT—cervical cancer	7.06e-05	0.000377	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—NOTCH2—cervical cancer	6.77e-05	0.000361	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—TERT—cervical cancer	6.76e-05	0.000361	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—NOTCH2—cervical cancer	6.66e-05	0.000356	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—NOTCH2—cervical cancer	6.65e-05	0.000355	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—NOTCH2—cervical cancer	6.62e-05	0.000354	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—HES1—cervical cancer	6.61e-05	0.000353	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—MTHFR—cervical cancer	6.61e-05	0.000353	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—NOTCH2—cervical cancer	6.6e-05	0.000353	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—NOTCH2—cervical cancer	6.54e-05	0.000349	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—FGFR3—cervical cancer	6.48e-05	0.000346	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—HES1—cervical cancer	6.46e-05	0.000345	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—HES1—cervical cancer	6.32e-05	0.000337	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—HES1—cervical cancer	6.29e-05	0.000336	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—FGFR3—cervical cancer	6.2e-05	0.000331	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—MTHFR—cervical cancer	6.16e-05	0.000329	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—NOTCH1—cervical cancer	6.08e-05	0.000325	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—MTHFR—cervical cancer	6.07e-05	0.000324	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—NOTCH1—cervical cancer	5.82e-05	0.000311	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TERT—cervical cancer	5.79e-05	0.000309	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—MTHFR—cervical cancer	5.69e-05	0.000304	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TERT—cervical cancer	5.66e-05	0.000302	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—HES1—cervical cancer	5.55e-05	0.000296	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TERT—cervical cancer	5.54e-05	0.000296	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TERT—cervical cancer	5.51e-05	0.000294	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CA9—cervical cancer	5.48e-05	0.000293	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—HES1—cervical cancer	5.46e-05	0.000292	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—HES1—cervical cancer	5.45e-05	0.000291	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—HES1—cervical cancer	5.43e-05	0.00029	CbGpPWpGaD
Desipramine—CHRM4—Signaling by GPCR—EGFR—cervical cancer	5.42e-05	0.000289	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—HES1—cervical cancer	5.41e-05	0.000289	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—HES1—cervical cancer	5.36e-05	0.000286	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—FGFR3—cervical cancer	5.31e-05	0.000284	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—FGFR3—cervical cancer	5.2e-05	0.000277	CbGpPWpGaD
Desipramine—CHRM5—Signaling by GPCR—EGFR—cervical cancer	5.19e-05	0.000277	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—FGFR3—cervical cancer	5.08e-05	0.000271	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—FGFR3—cervical cancer	5.06e-05	0.00027	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—NOTCH1—cervical cancer	4.99e-05	0.000266	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—MTHFR—cervical cancer	4.89e-05	0.000261	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—NOTCH1—cervical cancer	4.88e-05	0.000261	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TERT—cervical cancer	4.86e-05	0.00026	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—MTHFR—cervical cancer	4.79e-05	0.000256	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TERT—cervical cancer	4.78e-05	0.000255	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TERT—cervical cancer	4.77e-05	0.000255	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—NOTCH1—cervical cancer	4.77e-05	0.000255	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TERT—cervical cancer	4.76e-05	0.000254	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—NOTCH1—cervical cancer	4.75e-05	0.000253	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TERT—cervical cancer	4.74e-05	0.000253	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TERT—cervical cancer	4.7e-05	0.000251	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—MTOR—cervical cancer	4.56e-05	0.000243	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—FGFR3—cervical cancer	4.46e-05	0.000238	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—EGFR—cervical cancer	4.44e-05	0.000237	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—FGFR3—cervical cancer	4.39e-05	0.000234	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—FGFR3—cervical cancer	4.38e-05	0.000234	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—FGFR3—cervical cancer	4.37e-05	0.000233	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—MTOR—cervical cancer	4.36e-05	0.000233	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—FGFR3—cervical cancer	4.35e-05	0.000232	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—EGFR—cervical cancer	4.35e-05	0.000232	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—FGFR3—cervical cancer	4.31e-05	0.00023	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—EGFR—cervical cancer	4.25e-05	0.000227	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—EGFR—cervical cancer	4.23e-05	0.000226	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—CASP3—cervical cancer	4.19e-05	0.000224	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—NOTCH1—cervical cancer	4.19e-05	0.000224	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—NOTCH1—cervical cancer	4.12e-05	0.00022	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—NOTCH1—cervical cancer	4.11e-05	0.00022	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—NOTCH1—cervical cancer	4.1e-05	0.000219	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—NOTCH1—cervical cancer	4.09e-05	0.000218	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—NOTCH1—cervical cancer	4.05e-05	0.000216	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—CTNNB1—cervical cancer	4.04e-05	0.000216	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—CASP3—cervical cancer	4.01e-05	0.000214	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—CTNNB1—cervical cancer	3.87e-05	0.000207	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—MTOR—cervical cancer	3.74e-05	0.0002	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—EGFR—cervical cancer	3.73e-05	0.000199	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—MTHFR—cervical cancer	3.7e-05	0.000197	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—EGFR—cervical cancer	3.67e-05	0.000196	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—EGFR—cervical cancer	3.66e-05	0.000196	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—MTOR—cervical cancer	3.66e-05	0.000195	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—EGFR—cervical cancer	3.65e-05	0.000195	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—EGFR—cervical cancer	3.64e-05	0.000194	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—MTHFR—cervical cancer	3.61e-05	0.000193	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—EGFR—cervical cancer	3.61e-05	0.000193	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—MTOR—cervical cancer	3.58e-05	0.000191	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—MTOR—cervical cancer	3.56e-05	0.00019	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—STAT3—cervical cancer	3.52e-05	0.000188	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—CASP3—cervical cancer	3.44e-05	0.000184	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—MTHFR—cervical cancer	3.4e-05	0.000182	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—STAT3—cervical cancer	3.37e-05	0.00018	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—CASP3—cervical cancer	3.36e-05	0.00018	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—CTNNB1—cervical cancer	3.31e-05	0.000177	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—CASP3—cervical cancer	3.29e-05	0.000176	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—CASP3—cervical cancer	3.27e-05	0.000175	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—CTNNB1—cervical cancer	3.24e-05	0.000173	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—EGFR—cervical cancer	3.2e-05	0.000171	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—CTNNB1—cervical cancer	3.17e-05	0.000169	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—CTNNB1—cervical cancer	3.15e-05	0.000168	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MTOR—cervical cancer	3.14e-05	0.000168	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MTOR—cervical cancer	3.09e-05	0.000165	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MTOR—cervical cancer	3.08e-05	0.000165	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MTOR—cervical cancer	3.07e-05	0.000164	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—EGFR—cervical cancer	3.06e-05	0.000164	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MTOR—cervical cancer	3.06e-05	0.000164	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MTOR—cervical cancer	3.03e-05	0.000162	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—STAT3—cervical cancer	2.89e-05	0.000154	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CASP3—cervical cancer	2.89e-05	0.000154	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—MTHFR—cervical cancer	2.88e-05	0.000154	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CASP3—cervical cancer	2.84e-05	0.000152	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CASP3—cervical cancer	2.83e-05	0.000151	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—STAT3—cervical cancer	2.83e-05	0.000151	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CASP3—cervical cancer	2.83e-05	0.000151	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CASP3—cervical cancer	2.82e-05	0.00015	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CASP3—cervical cancer	2.79e-05	0.000149	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CTNNB1—cervical cancer	2.78e-05	0.000149	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—STAT3—cervical cancer	2.76e-05	0.000148	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—STAT3—cervical cancer	2.75e-05	0.000147	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CTNNB1—cervical cancer	2.74e-05	0.000146	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CTNNB1—cervical cancer	2.73e-05	0.000146	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CTNNB1—cervical cancer	2.72e-05	0.000145	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CTNNB1—cervical cancer	2.72e-05	0.000145	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CTNNB1—cervical cancer	2.69e-05	0.000144	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—TP53—cervical cancer	2.69e-05	0.000143	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—EGFR—cervical cancer	2.63e-05	0.00014	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—TP53—cervical cancer	2.57e-05	0.000137	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—EGFR—cervical cancer	2.57e-05	0.000137	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—EGFR—cervical cancer	2.51e-05	0.000134	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—EGFR—cervical cancer	2.5e-05	0.000133	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—STAT3—cervical cancer	2.43e-05	0.00013	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—STAT3—cervical cancer	2.39e-05	0.000127	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—STAT3—cervical cancer	2.38e-05	0.000127	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—STAT3—cervical cancer	2.37e-05	0.000127	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—STAT3—cervical cancer	2.37e-05	0.000126	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—STAT3—cervical cancer	2.34e-05	0.000125	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—MTHFR—cervical cancer	2.22e-05	0.000119	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—EGFR—cervical cancer	2.2e-05	0.000118	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TP53—cervical cancer	2.2e-05	0.000118	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—EGFR—cervical cancer	2.17e-05	0.000116	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—EGFR—cervical cancer	2.16e-05	0.000116	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—EGFR—cervical cancer	2.16e-05	0.000115	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TP53—cervical cancer	2.16e-05	0.000115	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—EGFR—cervical cancer	2.15e-05	0.000115	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—EGFR—cervical cancer	2.13e-05	0.000114	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TP53—cervical cancer	2.11e-05	0.000113	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TP53—cervical cancer	2.1e-05	0.000112	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TP53—cervical cancer	1.85e-05	9.88e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TP53—cervical cancer	1.82e-05	9.73e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TP53—cervical cancer	1.82e-05	9.7e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TP53—cervical cancer	1.81e-05	9.67e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TP53—cervical cancer	1.81e-05	9.64e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TP53—cervical cancer	1.79e-05	9.55e-05	CbGpPWpGaD
